Effects of opioids on the immune system

Neurochemical Research

Volumn 21, Issue 11, 1996, Pages 1375-1386

  Roy, Sabita ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

immune system; Opioids

Indexed keywords

BETA ENDORPHIN; MORPHINE; NALOXONE; OPIATE AGONIST; OPIATE RECEPTOR;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL VIABILITY; HELPER CELL; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR BINDING; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; THYMOCYTE;

EID: 0029856583     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02532379     Document Type: Article

References (71)

1. Sibinga, N. E. S., and Goldstein, A. 1988. Opioid peptides and opioid receptors in cells of the immune system. Ann. Rev. Immunol. 6:219-249.
2. Loh, H. H., Smith, A. P., and Lee, N. M. 1993. Effects of opioids on proliferation of mature and immature immune cells. Adv. Exp. Med. Biol. 335, 29-32.
3. Peterson, P. K., Molitor, T. W., Chao, and C. C. 1993. Mechanisms of morphine induced immunomodulation. Biochem. Pharmacol., 46:343-348.
4. Petrov, R. V., Mikhailova, A. A., Zakharova, L. A., Vasilenko, A. M., and Katlinsky, A. V. 1986. Myelopeptides-bone marrow mediators with immunostimulating and endorphin like activity. Scand. J. Immunol. 24:237-243.
5. Roy, S., Ramakrishnan, S., Loh, H. H., and Lee, N. M. 1991. Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow. Eur. J. Pharmacol., 195:359-363.
6. Roy, S., Sedqi, M., Ramakrishnan, S., Barke, R. A., and Loh, H. H. 1996. Differential effects of opioids on the proliferation of a macrophage cell line. Cell. Immunol. 169 271-277.
7. 3H- Morphine binding to Interleukin-1 activated thymocytes. J. of Pharmacol. and Expt. Therap., 263:451-456.
8. 3-opiate receptors. Eur. J. Pharmacol., 273:5-6.
9. Szabo, I., Rojavin, M., Bussiere, J. L., Eisenstein, T. K., Adler, M. W., and Rojers, T. J., 19??. Supression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J. Pharmacol. Expt. Therap., 267:703-706.
10. Sharp, B. M., Keane, W. F., Suh, H. J., Gekker, G., Tsukayama, D., and Peterson, P. K. 1985. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology, 117:793-795.
11. Mandler, R. N., Biddison, W. E., Mandler, R., and Serrate, S. A. 1986. Beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J. Immunol., 136, 934-939.
12. Koff, W. C., and Dunegon, M. A., 1985. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J. Immunol. 135, 350-354.
13. Fecho, K., Maslonek, K. A., Coussons-Read, M. E., Dykstra, L. A., and Lysle, D. T. 1994. Macrophage-derived nitric oxide is involved in the depressed con A-responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol. 152:5845-5852.
14. Lanier, L. L. 1995. Unusual lymphocytes-gd T cells and NK cells. The Immunologist 3:182-184.
15. Bayer, B. M., Daussin, S., Hernandez, M., and Irvin, L. 1990. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. NeuroPharmacology. 29:369-374.
16. Lysle, D. T., Coussons, M. E., Watts, V. J., Bennett, E. H., and Dykstra, L. A. 1993. Morphine-induced alterations of immune status: Dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Therap., 265:1071-1078.
17. Pacifici, R., Patrini, G., Venier, I., Parolaro, D., Zuccarro, P., and Gori, E. 1994. Effect of morphine and methadone acute treatment on immunological activity in mice: pharmacokinetic and pharmacodynamic correlates. J. Pharmacol. Exp. Ther., 269:1112-1116.
18. Carr, D. J., and France, C. P., 1993. Immune alterations in chronic morphine treated rhesus monkeys. Adv. Exp. Med. Biol., 335:35-39.
19. Page, G. G., Ben-Eliyahu, S., and Yirmiya, R. 1993. Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain, 54:21-8.
20. Colacchio, T. A., Yeager, M. P., and Hildebrandt, L. W. 1994. Perioperative immunomodulation in cancer surgery. Am. J. Surg. 167:174-179.
21. Fuchs, B. A., and Pruett, S. B. 1993. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: involvement of both opiate and glucocorticoid receptors. J. Pharmacol. Exp. Therap., 266:417-423.
22. Bryant, H. U., Yoburn, B. C., Intrissi, C. E., Bernton, E. W., and Holaday, J. W. 1988. Immunosuppressive effects of chronic morphine treatment. Eur. J. Pharm., 149:165-169.
23. Bryant, H. U., Bernton, E. W., Kenner, J. R., and Holaday, J. W. 1991. Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology. 128: 3253-3258.
24. Lafferty, K. J. 1995. Role of second signals in the induction of T cells and graft rejection. The Immunologist. 3:256-258.
25. Sei, Y., Yoshimoto, K., McIntyre, T., Skolnick, P., and Arora, P. K. 1991. Morphine induced thymic hypoplasia is glucocorticoid dependent. J. Immunol. 146:194-198.
26. Meuer, S. C., and Meyer zum Buschenfelde, K. H. 1993. T-cell receptor induces responsiveness to IL-1 and IL-2 but does not lead to T-cell proliferation. J. Immunol., 136:4106-4112.
27. Smith, K. A. 1989. The IL-2 receptor. Ann. Rev. Cell. Biol. 5: 397-425.
28. Roy, S., Loh, H. H., and Barke, R. A. 1995. Morphine-induced suppression of thymocyte proliferation is mediated by inhibition of IL-2 synthesis. Adv. in Exp. Medicine. Biology. 373:41-8.
29. Roy, S., Chapin, R., Cain, K., Charboneau, R., and Horace H. Loh Barke, R. A. 1996. Morphine inhibits transcriptional regulation of IL-2 synthesis. J. Imm. (submitted)
30. Madden, J. J., and Donahue, R. M. 1990. Opioid binding to cells of the immune system in Drugs of Abuse and the Immune system pages 212-224 in Watson, R. R., ed. CRC Press, Boca Raton, Fl.
31. Shahabi, N. A., and Sharp, B. M., 1995. Antiproliferative effects of δ opioids on highly purified CD4 and CD8 murine T cells. J. Pharmacol. Exp. Therap., 273:1105-1113.
32. Adler, M. W., Geller, E. B., Rogers, T. J., Henderson, E. E., and Eisenstein, T. K. 1993. Opioids receptor and immunity. Adv. Exp. Med. Biol., 335:13-20.
33. Bussiere, J. L., Adler, M. W., Rogers, R. J., and Eisenstein T. K. 1993. Cytokine reversal of morphineinduced supression of the Antibody response. J. Pharmacol. Exp. Therap., 264:591-597.
34. Taub, D. D., Eisenstein, T. K., Geller, E. B., Adler, M. W., and Rogers, T. J. 1991. Immunomodulatory activity of μ and κ-selective opioid agonists. Proc. Natl. Acad. Sci. (USA) 88:360-364.
35. Paul W. E., Ohara, J., 1987. B cell stimulatory factor. Ann. Rev. Immunol., 5:429.
36. Park, L. S., Friend, D., Gillis, S., and Urdal, D. L. 1986. Characterization of the cell surface receptor for a multi lineage colony stimulating factor. J. Biol. Chem., 261:205.
37. Sedqui, M., Roy, S., Ramakrishnan, S., Elde, R., and Loh, H. H. 1995. Complementary cloning of a mu-opioid receptor from rat peritoneal macrophage. Biochem. Biophys. Res. Commun. 208: 563-574.
38. Wick, M. J., Minnerath, S. R., Roy, S., Ramakrishnan, S., and Loh, H. H. 1996. Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes. Neuroimmunology 64:29-36.
39. Chuang, T. K., Killam, K. F., Chuang, L. F., Kung, H.-F., Sheng, W. S., Chao, C. C., Yu, L., and Chuang, R. Y. 1995. Mu opioid receptor gene expression in immune cells. Biochem. Biophys. Res. Commun., 216:922-930.
40. Sedqi, M., S. Roy, S. Ramakrishnan, R., and Loh, H. H. 1996. Expression cloning of full-length cDNA encoding delta opioid receptor from mouse thymocytes. J. Neuroimmunol. (in press).
41. Meunier, J. C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J. L., Guillemot, J. C., Ferrara, P., and Monsarrat, B., et. al., 1995. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 377: 532-535.
42. Wick, M. J., Minnerath, S. R., Roy, S., Ramakrishnan, S., and Loh, H. H. 1995. Expression of alternate forms of brain opioid "orphan" receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. Mol. Brain. Res., 32:342-347.
43. Milligan, C. E., Webster, L., Piros, E. T., Evans, C. J., Cunningham, T. J., and Levitt, P. 1995. Induction of opioid receptor mediated macrophage chemotactic activity after neonatal brain injury. J. Immunol. 154:6571-81.
44. Zhou, Y., Scamurra, R., Molitor, T. W., and Murtaugh, M. P. 1992. Characterization of transforming growth factor beta 1 gene expression in porcine imune cells Mol. Immunol. 29:965-70.
45. Iuvone, T., Capasso, A., D'Acquisto, F., and Carnuccio, R. 1995. Opioids inhibit the induction of nitric oxide synthase in J774 macrophages. Biochem. Biophys. Res. Comm. 212:975-80.
46. Pacifici, R., Di Carlo, S., Bacosi, A., and Zuccaro, P. 1993. Macrophage functions in drugs of abuse-treated mice. Int. J. Immunopharmacol. 15:711-6.
47. Belkowski, S. M., Alicea, C., Eisenstein, T. K., Rogers, T. J. 19??. Inhibition of interleukin I and Tumor necrosis factor alpha synthesis following treatment of macrophages with the kappa opioid ligand U50, 488H. J. Pharmacol. Exp. Therap. 273:1491-96.
48. Levier, D. G., Brown, R. D., McCay, J. A., Fuchs, B. A., Harris, L. S., and Munson, A. E. 1993. Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets. J. Pharmacol. Exp. Therap. 267:357-63.
49. Rojavin, M., Szabo, I., Bussiere, J. L., Rogers, T. J., Adler, M. W., and Eisenstein T. K. 1993. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci. 53:997-1006.
50. Stefano, G. B., Bilfinger, T. V. 1993. Human neutrophil and macrophage chemokinesis induced by cardiopulmonary bypass:loss of DAME and IL-1 chemotaxis. J. Neuroimmunol. 47:189-97.
51. Singhal, P. C., Pan, C., and Gibbons, N. 1993. Effect of morphine on uptake of immunoglobulin G complexes by mesangial cells and macrophages. Am. J. Physiol. 264:F859-66.
52. Sergeeva, M. G., Terentjeva, I. V., Mevkh, A. T., and Varfolomeev, S. D. 1993. Direct influence of morphine on the release of arachidonic acid and its metabolites. FEBS Lett. 323:163-5.
53. Yeager, M. P., Colacchio, T. A., Yu, C. T., Hildebrandt, L., Howell, A. L., Weiss, J., and Guyre, P. M. 1995. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 83:500-8.
54. Flores, L. R., Hernandez, M. C., and Bayer, B. M. 1994. Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors. J. Pharmacol. Exp. Therap. 26:1129-34.
55. Garza, H. H., Jr., Prakash, O., and Carr, D. J. 1994. Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity. Int. J. Immunopharmacol. 16:1061-70.
56. di Francesco, P., Gaziano, R., Casalinuovo, I. A., Belogi, L., Palamara, A. T., Favalli, C., and Garaci E. 1994. Combined effect of fluconazole and thymosin alpha 1 on systemic candidiasis in mice immunosuppressed by morphine treatments. Clinical Experimental Immunol. 97:347-52.
57. Freier, D. O., Fuchs, B. A. 1994. A mechanism of action for morphine-induced immunosuppression:corticosterone mediates morphine-induced suppression of natural killer cell activity. J. Pharmacol. Experimental Therap. 270:1127-33.
58. Kimes, A. S., Smith, W. J., Winchell, C. J., and London, E. D. 1992. Effects of morphine on the phenotypic expression of cell surface markers on murine lymphocytes. Life Sci. 51:807-15.
59. Chuang, L. F., Killam, K. F., Jr., and Chuang, R. Y. 1993. Opioid dependency and T-helper cell functions in rhesus monkey. In Vivo. 7:159-66.
60. Freier, D. O., and Fuchs, B. A. 1993. Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice. J. Pharmacol. Exp. Therap. 265:81-8.
61. Luza, J. 1992. The effect of morphine on lymphocyte viability in vitro. Acta Universitatis Palackianae Olomucensis Facultatis Medicae. 134:43-5.
62. Lopez, M. C., Chen, G. J., Colombo, L. L., Huang, D. S. Darban, H. R., Watzl, B., and Watson, R. R. 1993. Spleen and thymus cell subsets modified by long-term morphine administration and murine AIDS - II. International J. Immunopharmacol. 15(8):909-18.
63. Carpenter, G. W., Garza, H. H., Jr., Gebhardt, B. M., and Carr, D. J. 1994. Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen. Brain, Behavior, Immunity. 8:185-203.
64. Carr, D. J., Carpenter, G. W., Garza, H. H., Jr., Baker, M. L., and Gebhardt, B. M. 1995. Cellular mechanisms involved in morphine-mediated suppression of CTL activity. [Review] Adv. Exp. Med. & Biol. 373:131-9.
65. Flores, L. R., Wahl, S. M., and Bayer, B. M. 1995. Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking. J. Pharmacol. & Exp. Therap. 272:1246-51.
66. Madden, J. J., Ketelsen, D., Whaley, W. L., Donahoe, R. M., and Oleson, D. 1995. Mitogenic activation of human T lymphocytes induces a high affinity morphine binding site. Adv. Exp. Medicine & Biology. 373:37-40.
67. Carr, D. J., and France, C. P. 1993. Immune alterations in morphine-treated rhesus monkeys. J. Pharmacol. Exp. Therap. 267:9-15.
68. Bhargava, H. N., House, R. V., Thorat, S. N., and Thomas, P. T. 1995. Effects of naltrexone on morphine-induced tolerance and physical dependence and changes in cellular immune function in mice. Brain Res. 690:121-6.
69. Sawant, S. G., and Couch, D. B. 1995. Induction of micronuclei in murine lymphocytes by morphine. Env. & Mol. Mutagenesis. 25:279-83.
70. Shaker, M., Shahabi, N. A., and Sharp, B. M. 1994. Expression of naloxone-resistant beta-endorphin binding sites on A20 cells: effects of concanavalin A and dexamethasone. Immunopharmacol. 28:183-92.
71. Przewlocki, R., Hassan, A. H., Lason, W., Epplen, C., Herz, A., and Stein, C. 1992. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience. 48:491-500.